In 2022, U.S. national health expenditure as a share of its gross domestic product (GDP) reached 17.3 percent, this was a decrease on the previous year. The United States has the highest health spending based on GDP share among developed countries. Both public and private health spending in the U.S. is much higher than other developed countries. Why the U.S. pays so much moreWhile private health spending in Canada stays at around three percent and in Germany under two percent of the gross domestic product, it is nearly nine percent in the United States. Another reason for high costs can be found in physicians’ salaries, which are much higher in the U.S. than in other wealthy countries. A general practitioner in the U.S. earns nearly twice as much as the average physician in other high-income countries. Additionally, medicine spending per capita is also significantly higher in the United States. Finally, inflated health care administration costs are another of the predominant factors which make health care spending in the U.S. out of proportion. It is important to state that Americans do not pay more because they have a higher health care utilization, but mainly because of higher prices. Expected developmentsBy 2031, it is expected that health care spending in the U.S. will reach nearly one fifth of the nation’s gross domestic product. Or in dollar-terms, health care expenditures will accumulate to about seven trillion U.S. dollars in total.

In November 2024, gasoline prices were around 8.1 percent lower than in November 2023. The data represents city averages in the United States. The defined base period is: 1982-84=100. CPI is defined by the United States Bureau of Labor Statistics as "a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services". It is based on prices of food, clothing, shelter, fuels, transportation fares, charges for doctors’ and dentists’ services, drugs, and other goods and services that people buy for day-to-day living. The annual inflation rate in the U.S. since 1990 can be accessed here.

Graph and download economic data for Federal Government: Current Expenditures (FGEXPND) from Q1 1947 to Q4 2024 about expenditures, federal, government, GDP, and USA.

Government spending in the United States was last recorded at 34.4 percent of GDP in 2023 . This dataset provides - United States Government Spending To Gdp- actual values, historical data, forecast, chart, statistics, economic calendar and news.

The ratio of government expenditure to GDP in the United States was forecast to decrease between 2024 and 2029 by in total 0.5 percentage points. This overall decrease does not happen continuously, notably not in 2026. According to this forecast, in 2029, the ratio will have decreased for the third consecutive year to 37.08 percent. Shown here is the general government expenditure as a share of the national gross domestic product. As defined by the International Monetary Fund, the general government expenditure consists of total expense and the net acquisition of nonfinancial assets. The gross domestic product represents the total value of final goods and services produced during a year.Find more statistics on other topics about the United States with key insights such as the annual change in imports of trade goods and services, the number of employed people, and ratio of the national debt to the gross domestic product.

Graph and download economic data for Shares of gross domestic product: Personal consumption expenditures (DPCERE1Q156NBEA) from Q1 1947 to Q4 2024 about Shares of GDP, PCE, consumption expenditures, consumption, personal, GDP, and USA.

Graph and download economic data for Government current expenditures: Health (G160271A027NBEA) from 1959 to 2023 about health, expenditures, government, GDP, and USA.

For the fiscal year of 2025, mandatory government spending is predicted to sum up to about 4.37 trillion U.S. dollars. It consists primarily of benefit programs such as: social security, Medicare, Medicaid, as well as other programs. Discretionary spending consists of spending controlled by lawmakers through annual appropriation acts. In FY 2025 it is proposed at 1.93 trillion U.S. dollars, and is divided into defense and nondefense spending. Spending for net interest is also listed, which consists of the government's interest payments on debt held by the public, offset by interest income the government receives.

Graph and download economic data for Federal government total expenditures (W019RCQ027SBEA) from Q3 1959 to Q4 2024 about expenditures, federal, government, GDP, and USA.

Household final consumption expenditure (formerly private consumption) is the market value of all goods and services, including durable products (such as cars, washing machines, and home computers), purchased by households. It excludes purchases of dwellings but includes imputed rent for owner-occupied dwellings. It also includes payments and fees to governments to obtain permits and licenses. Here, household consumption expenditure includes the expenditures of nonprofit institutions serving households, even when reported separately by the country. Data are in current U.S. dollars.

In 2023, the lowest 20 percent of income consumer units spent about 41.3 percent of their total expenditure on housing. Consumer units belonging to the highest 20 percent of income spent only 29.2 percent on housing. Additionally, those in the highest income quintile spent 17.7 percent of their total expenditure on personal insurance and pensions, while the lowest 20 percent spent only 2.1 percent.

United States US: GERD: % of GDP data was reported at 3.586 % in 2022. This records an increase from the previous number of 3.483 % for 2021. United States US: GERD: % of GDP data is updated yearly, averaging 2.612 % from Dec 1981 (Median) to 2022, with 42 observations. The data reached an all-time high of 3.586 % in 2022 and a record low of 2.268 % in 1981. United States US: GERD: % of GDP data remains active status in CEIC and is reported by Organisation for Economic Co-operation and Development. The data is categorized under Global Database’s United States – Table US.OECD.MSTI: Gross Domestic Expenditure on Research and Development: OECD Member: Annual.

For the United States, from 2021 onwards, changes to the US BERD survey questionnaire allowed for more exhaustive identification of acquisition costs for ‘identifiable intangible assets’ used for R&D. This has resulted in a substantial increase in reported R&D capital expenditure within BERD. In the business sector, the funds from the rest of the world previously included in the business-financed BERD, are available separately from 2008. From 2006 onwards, GOVERD includes state government intramural performance (most of which being financed by the federal government and state government own funds). From 2016 onwards, PNPERD data are based on a new R&D performer survey. In the higher education sector all fields of SSH are included from 2003 onwards.

Following a survey of federally-funded research and development centers (FFRDCs) in 2005, it was concluded that FFRDC R&D belongs in the government sector - rather than the sector of the FFRDC administrator, as had been reported in the past. R&D expenditures by FFRDCs were reclassified from the other three R&D performing sectors to the Government sector; previously published data were revised accordingly. Between 2003 and 2004, the method used to classify data by industry has been revised. This particularly affects the ISIC category “wholesale trade” and consequently the BERD for total services.

U.S. R&D data are generally comparable, but there are some areas of underestimation:

1. i) Up to 2008, Government sector R&D performance covers only federal government activities. That by State and local government establishments is excluded;
2. ii) Except for the Government and the Business Enterprise sectors, the R&D data exclude most capital expenditures. For the Business Enterprise sector, depreciation is reported in place of gross capital expenditures up to 2014. Higher education (and national total) data were revised back to 1998 due to an improved methodology that corrects for double-counting of R&D funds passed between institutions.

Breakdown by type of R&D (basic research, applied research, etc.) was also revised back to 1998 in the business enterprise and higher education sectors due to improved estimation procedures.

The methodology for estimating researchers was changed as of 1985. In the Government, Higher Education and PNP sectors the data since then refer to employed doctoral scientists and engineers who report their primary work activity as research, development or the management of R&D, plus, for the Higher Education sector, the number of full-time equivalent graduate students with research assistantships averaging an estimated 50 % of their time engaged in R&D activities. As of 1985 researchers in the Government sector exclude military personnel. As of 1987, Higher education R&D personnel also include those who report their primary work activity as design.

Due to lack of official data for the different employment sectors, the total researchers figure is an OECD estimate up to 2019. Comprehensive reporting of R&D personnel statistics by the United States has resumed with records available since 2020, reflecting the addition of official figures for the number of researchers and total R&D personnel for the higher education sector and the Private non-profit sector; as well as the number of researchers for the government sector. The new data revise downwards previous OECD estimates as the OECD extrapolation methods drawing on historical US data, required to produce a consistent OECD aggregate, appear to have previously overestimated the growth in the number of researchers in the higher education sector.

Pre-production development is excluded from Defence GBARD (in accordance with the Frascati Manual) as of 2000. 2009 GBARD data also includes the one time incremental R&D funding legislated in the American Recovery and Reinvestment Act of 2009. Beginning with the 2000 GBARD data, budgets for capital expenditure – “R&D plant” in national terminology - are included. GBARD data for earlier years relate to budgets for current costs only.

Graph and download economic data for Real personal consumption expenditures: Transportation services (DTRSRX1Q020SBEA) from Q1 2007 to Q4 2024 about transportation, PCE, consumption expenditures, consumption, personal, services, real, GDP, and USA.

United States US: Government-Financed GERD: % of GDP data was reported at 0.650 % in 2022. This records a decrease from the previous number of 0.654 % for 2021. United States US: Government-Financed GERD: % of GDP data is updated yearly, averaging 0.786 % from Dec 1981 (Median) to 2022, with 42 observations. The data reached an all-time high of 1.245 % in 1985 and a record low of 0.650 % in 2022. United States US: Government-Financed GERD: % of GDP data remains active status in CEIC and is reported by Organisation for Economic Co-operation and Development. The data is categorized under Global Database’s United States – Table US.OECD.MSTI: Gross Domestic Expenditure on Research and Development: OECD Member: Annual.

For the United States, from 2021 onwards, changes to the US BERD survey questionnaire allowed for more exhaustive identification of acquisition costs for ‘identifiable intangible assets’ used for R&D. This has resulted in a substantial increase in reported R&D capital expenditure within BERD. In the business sector, the funds from the rest of the world previously included in the business-financed BERD, are available separately from 2008. From 2006 onwards, GOVERD includes state government intramural performance (most of which being financed by the federal government and state government own funds). From 2016 onwards, PNPERD data are based on a new R&D performer survey. In the higher education sector all fields of SSH are included from 2003 onwards.

Following a survey of federally-funded research and development centers (FFRDCs) in 2005, it was concluded that FFRDC R&D belongs in the government sector - rather than the sector of the FFRDC administrator, as had been reported in the past. R&D expenditures by FFRDCs were reclassified from the other three R&D performing sectors to the Government sector; previously published data were revised accordingly. Between 2003 and 2004, the method used to classify data by industry has been revised. This particularly affects the ISIC category “wholesale trade” and consequently the BERD for total services.

U.S. R&D data are generally comparable, but there are some areas of underestimation:

1. i) Up to 2008, Government sector R&D performance covers only federal government activities. That by State and local government establishments is excluded;
2. ii) Except for the Government and the Business Enterprise sectors, the R&D data exclude most capital expenditures. For the Business Enterprise sector, depreciation is reported in place of gross capital expenditures up to 2014. Higher education (and national total) data were revised back to 1998 due to an improved methodology that corrects for double-counting of R&D funds passed between institutions.

Breakdown by type of R&D (basic research, applied research, etc.) was also revised back to 1998 in the business enterprise and higher education sectors due to improved estimation procedures.

The methodology for estimating researchers was changed as of 1985. In the Government, Higher Education and PNP sectors the data since then refer to employed doctoral scientists and engineers who report their primary work activity as research, development or the management of R&D, plus, for the Higher Education sector, the number of full-time equivalent graduate students with research assistantships averaging an estimated 50 % of their time engaged in R&D activities. As of 1985 researchers in the Government sector exclude military personnel. As of 1987, Higher education R&D personnel also include those who report their primary work activity as design.

Due to lack of official data for the different employment sectors, the total researchers figure is an OECD estimate up to 2019. Comprehensive reporting of R&D personnel statistics by the United States has resumed with records available since 2020, reflecting the addition of official figures for the number of researchers and total R&D personnel for the higher education sector and the Private non-profit sector; as well as the number of researchers for the government sector. The new data revise downwards previous OECD estimates as the OECD extrapolation methods drawing on historical US data, required to produce a consistent OECD aggregate, appear to have previously overestimated the growth in the number of researchers in the higher education sector.

Pre-production development is excluded from Defence GBARD (in accordance with the Frascati Manual) as of 2000. 2009 GBARD data also includes the one time incremental R&D funding legislated in the American Recovery and Reinvestment Act of 2009. Beginning with the 2000 GBARD data, budgets for capital expenditure – “R&D plant” in national terminology - are included. GBARD data for earlier years relate to budgets for current costs only.

The largest proportion of household expenditure on healthcare goods and services in Mexico is allocated towards medication, accounting for more than 44 percent of the total as of 2023. This is as much as all three following categories added together. Hospital services and medical visits account for around 15 percent each, while support goods such as soap, disinfectant, and toothpaste make up approximately 11.4 percent of the total. The cost of medication Mexico ranks second among seven Latin American economies in terms of medicine prices, with an average cost of 32.8 U.S. dollars per medication in 2024. In comparison, the average price in Peru was 9.9 U.S. dollars. Cardiovascular medicines such as those for hypertension and heart disease were particularly expensive, averaging 46.9 U.S. dollars per unit. Additionally, medication for respiratory diseases, mental and behavioral disorders, and those targeting the musculoeskeletal system were also among the costliest, with averages ranging from 28 to 40 U.S. dollars. Healthcare expenditure Mexico's overall healthcare spending as a percentage of GDP remains relatively low. In 2023, healthcare expenditure represented an estimated 5.7 percent of the country's GDP, a decrease from previous years. This figure is significantly lower than that of other OECD countries, with the United States allocating approximately 16.5 percent of its GDP to health care during that year. Within Latin America, Mexico has one of the lowest healthcare expenditures as a share of its GDP.

Graph and download economic data for Personal consumption expenditures per capita (A794RC0Q052SBEA) from Q1 1947 to Q4 2024 about PCE, consumption expenditures, per capita, consumption, personal, GDP, and USA.

The global total consumer spending in was forecast to continuously increase between 2024 and 2029 by in total 16.2 trillion U.S. dollars (+26.61 percent). After the ninth consecutive increasing year, the consumer spending is estimated to reach 77.1 trillion U.S. dollars and therefore a new peak in 2029. Consumer spending here refers to the domestic demand of private households and non-profit institutions serving households (NPISHs). Spending by corporations and the state is not included. The forecast has been adjusted for the expected impact of COVID-19.Consumer spending is the biggest component of the gross domestic product as computed on an expenditure basis in the context of national accounts. The other components in this approach are consumption expenditure of the state, gross domestic investment as well as the net exports of goods and services. Consumer spending is broken down according to the United Nations' Classification of Individual Consumption By Purpose (COICOP). As not all countries and regions report data in a harmonized way, all data shown here has been processed by Statista to allow the greatest level of comparability possible. The underlying input data are usually household budget surveys conducted by government agencies that track spending of selected households over a given period.The data is shown in nominal terms which means that monetary data is valued at prices of the respective year and has not been adjusted for inflation. For future years the price level has been projected as well. The data has been converted from local currencies to US$ using the average exchange rate of the respective year. For forecast years, the exchange rate has been projected as well. The timelines therefore incorporate currency effects.Find more key insights for the total consumer spending in countries like North America and Europe.

US: GDP: Value Added: Current PPP data was reported at 16,340.388 USD bn in 2022. This records an increase from the previous number of 14,962.179 USD bn for 2021. US: GDP: Value Added: Current PPP data is updated yearly, averaging 6,968.773 USD bn from Dec 1981 (Median) to 2022, with 42 observations. The data reached an all-time high of 16,340.388 USD bn in 2022 and a record low of 2,097.284 USD bn in 1981. US: GDP: Value Added: Current PPP data remains active status in CEIC and is reported by Organisation for Economic Co-operation and Development. The data is categorized under Global Database’s United States – Table US.OECD.MSTI: Gross Domestic Product, GDP PPP and GDP Deflator: OECD Member: Annual.

Graph and download economic data for State and Local Government Current Expenditures (SLEXPND) from Q1 1947 to Q4 2024 about state & local, expenditures, government, GDP, and USA.

In 2023, the United States had the highest per capita health expenditure among OECD countries. At that time, per capita health expenditure in the U.S. amounted over 13,432 U.S. dollars, significantly higher than in Switzerland, the country with the second-highest per capita health expenditure. Norway, Germany and Austria are also within the top five countries with the highest per capita health expenditure. The United States also spent the highest share of it’s gross domestic product on health care, with 16.5 percent of its GDP spent on health care services. Health Expenditure in the U.S. The United States is the highest spending country worldwide when it comes to health care. In 2022, total health expenditure in the U.S. exceeded four trillion dollars. Expenditure as a percentage of GDP is projected to increase to approximately 20 percent by the year 2031. Distribution of Health Expenditure in the U.S. Health expenditure in the United States is spread out across multiple categories such as nursing home facilities, home health care, and prescription drugs. As of 2022, the majority of health expenditure in the United States was spent on hospital care, accounting for a bit less than one third of all health spending. Hospital care was followed by spending on physician and clinical services which accounted for 20 percent of overall health expenditure.